Human Chorionic Gonadotropin (hCG)

Endogenous Glycoprotein Hormone / FDA-approved prescription biologic (indication-specific)

Human chorionic gonadotropin is a placental glycoprotein hormone and prescription biologic that acts as an LH receptor agonist, used in indication-specific fertility and gonadal function protocols.

Calculate Dose

For research use only.

Key Facts

CAS
โ€”
Molecular Weight (MW)
Variable glycoprotein; approximately 36.7 to 38 kDa depending on glycosylation/source
Half-life
~24-36 hours biological half life (route and product dependent)
Unit
IU
Administration Route
Intramuscular; some products/routes vary by labeling and clinical context
Frequency
Protocol dependent
Last updated
3/10/2026
Targets
LH/CG receptor

Overview

Human chorionic gonadotropin is a placental glycoprotein hormone and prescription biologic that acts as an LH receptor agonist, used in indication-specific fertility and gonadal function protocols.

Protocol

Dosage Range
Common labeled doses range from 500 to 10000 USP units depending on indication
Frequency
Protocol dependent
Cycle
Use only per FDA labeling / prescriber direction
Administration Route
Intramuscular; some products/routes vary by labeling and clinical context
Reconstitution Guide
Reconstitute only per product labeling with supplied diluent; store as directed after reconstitution

Science

Mechanism of Action

Acts as an LH receptor agonist to stimulate testicular testosterone production in males and trigger final follicular maturation/ovulation in female fertility protocols.

Targets

LH/CG receptor

Studies

  • โ€” Journal/year not available
  • โ€” Journal/year not available
  • โ€” Journal/year not available

Benefits

Supports testosterone production in appropriate male medical contextsUsed in selected cases of hypogonadotropic hypogonadismUsed in fertility protocols for ovulation triggeringUsed in selected pediatric cryptorchidism protocols

Potential Side Effects

  • Injection site reactions
  • Headache
  • Mood changes
  • Gynecomastia
  • Fluid retention
  • Acne
  • Risk of ovarian hyperstimulation syndrome in female fertility use

References

Related peptides